Catheter Precision, Inc. closed the sale and issuance of 3,470 shares of Series C-3 Convertible Preferred Stock for aggregate gross proceeds of $3,470,000. The preferred stock is convertible into common stock at an initial conversion price of $0.632 per share, subject to a floor price of $0.35 per share. The company intends to use the net proceeds for working capital, loan repayment, and general corporate purposes. Catheter Precision, Inc. operates in the medical device industry and develops precision catheter technology.
